For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Cytomx Therapeutics, Inc.

USPTO Granted Patents = 84

CIPO Patents = 4

EPO Patents = 11

Trademarks = 3

Forward Citations = 1,171

Loading Chart...

Loading Chart...

71 inventors (with patents filed for the assignee):

James William West (47 out of 79 patents)

Jason Gary Sagert (42 out of 48 patents)

Olga Vasiljeva (27 out of 27 patents)

4. Daniel Robert Hostetter (21 out of 21 patents)

5. Nancy E Stagliano (20 out of 41 patents)

6. Luc Roland Desnoyers (19 out of 141 patents)

7. Stephen James Moore (19 out of 23 patents)

8. Henry Bernard Lowman (17 out of 94 patents)

9. Kathryn Kamath (16 out of 16 patents)

10. Jonathan Alexander Terrett (13 out of 36 patents)

11. Patrick Sean Daugherty (13 out of 33 patents)

12. Paul Henry Bessette (13 out of 27 patents)

13. Margaret Thy Luu Nguyen (12 out of 12 patents)

14. Shouchun Liu (11 out of 11 patents)

15. Elizabeth-Edna Mary Menendez (11 out of 11 patents)

Core Competencies:

Activatable Antibodies

Bispecific Antibodies

Matrix Metalloprotease

Cytokine Constructs

Protease Activity Detection

EGFR Binding

Anti-CD40 Antibodies

Anti-PDL1 Antibodies

Multispecific Antibodies

Polypeptide Display

Therapeutic Antibodies

Cleavable Substrates

84 patents: Sort by Forward Citations

1. 12460017 - Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof (2025-11-04),

2. 12459999 - Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof (2025-11-04),

3. 12441799 - Activatable anti-CTLA-4 antibodies and uses thereof (2025-10-14),

4. 12428470 - Compositions containing activatable antibodies (2025-09-30),

5. 12209120 - Activatable anti-VEGF scFv (2025-01-28),

6. 12139816 - Protease-resistant systems for polypeptide display and methods of making and using thereof (2024-11-12),

7. 12139543 - Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR (2024-11-12),

8. 12091442 - Activatable cytokine constructs and related compositions and methods (2024-09-17),

9. 12049505 - Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof (2024-07-30),

10. 11992528 - Compositions and methods for conjugating activatable antibodies (2024-05-28),

11. 11952427 - Anti-CD40 antibodies and uses thereof (2024-04-09),

12. 11890354 - Activatable antibodies that bind epidermal growth factor receptor and methods thereof (2024-02-06),

13. 11884746 - Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof (2024-01-30),

14. 11867695 - Compositions and methods for detecting protease activity in biological systems (2024-01-09),

15. 11859010 - Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof (2024-01-02),

CytomX Therapeutics, Inc. is a biopharmaceutical company specializing in the development of innovative antibody therapeutics. With a focus on Probody™ therapeutics, CytomX is leveraging its proprietary platform to create novel, potentially more effective treatments for cancer and other serious diseases. Probody™ therapeutics are designed to selectively target tumor cells while sparing healthy tissue, aiming to improve the therapeutic index of drugs and reduce side effects. CytomX is committed to advancing the field of precision medicine and improving patient outcomes through its groundbreaking research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

84 Patents

#14 in South San Francisco, CA

#1,011 in California

#4,279 in US

#8,813 in the World

South San Francisco, CA, United States of America

Cytomx Therapeutics, Inc.

Forward Citations = 1,171

71 inventors:

James William West (47 out of 79 patents)

Jason Gary Sagert (42 out of 48 patents)

Olga Vasiljeva (27 out of 27 patents)

4. Daniel Robert Hostetter (21 out of 21 patents)

5. Nancy E Stagliano (20 out of 41 patents)

Please report any incorrect information to support@idiyas.com

Loading…